Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles

PURPOSE: Conventional chemotherapy is hampered by the presence of breast cancer stem cells (BCSCs). It is crucial to eradicating both the bulky breast cancer cells and BCSCs, using a combination of conventional chemotherapy and anti-CSCs drugs. However, the synergistic ratio of drug combinations can...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jie, Liu, Junjie, Xie, Fangyuan, Lu, Ying, Yin, Chuan, Shen, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884979/
https://www.ncbi.nlm.nih.gov/pubmed/32063706
http://dx.doi.org/10.2147/IJN.S230376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884979/
https://www.ncbi.nlm.nih.gov/pubmed/32063706
http://dx.doi.org/10.2147/IJN.S230376

Ejemplares similares